TY  - GEN
AU  - Toth,Peter P
AU  - Stevens,Warren
AU  - Chou,Jacquelyn W
TI  - Why published studies of the cost-effectiveness of PCSK-9 inhibitors yielded such markedly different results
SN  - 1941-837X
PY  - 2019///0708
KW  - Cardiovascular Diseases
KW  - economics
KW  - Cost-Benefit Analysis
KW  - methods
KW  - Humans
KW  - Hypolipidemic Agents
KW  - Models, Econometric
KW  - PCSK9 Inhibitors
KW  - Quality-Adjusted Life Years
KW  - Risk Assessment
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1080/13696998.2017.1327440
ER  -